ADRIAN FELDER: Open Payments
NPI 1518435197 · PLANO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$28,500 in 124 payments from 10 companies in 2025. Trend: 2023 $17,169 · 2024 $28,110 · 2025 $28,500
Consulting: $11,315Travel & lodging: $7,997Speaker / faculty: $6,475Food & beverage: $2,587Education: $126
| Company | Payments | Amount |
|---|---|---|
| Johnson & Johnson Health Care Systems Inc. | 21 | $11,523 |
| United Therapeutics Corporation | 49 | $9,593 |
| Merck Sharp & Dohme LLC | 17 | $3,586 |
| Actelion Pharmaceuticals US, Inc. | 29 | $3,404 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $205 |
| Amgen Inc. | 1 | $93 |
| Recor Medical Inc | 2 | $43 |
| IDORSIA PHARMACEUTICALS US INC | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
| Liquidia Technologies, Inc. | 1 | $17 |
Products named: OPSUMIT, UPTRAVI, WINREVAIR, Adempas, TYVASO, OPSYNVI, REPATHA, Paradise Ultrasound Renal Denervation System.
Industry payments across TX — which companies pay providers there.
